We next conducted a pan-cancer analysis of alternative splicing across 33 cancer types using the TCGA Spliceseq dataset18 to study whether DAP3-modulated splicing events are frequently dysregulated in different cancer types and evaluate their clinical significance. The gene discussed is DAP3; the disease is cancer.